Bz-L-Lys-OMe*HCl

Bz-L-Lys-OMe*HCl is an N-benzylcarbonyl (Bz) protected L-lysine methyl ester hydrochloride, presenting the ε-amino side chain and α-carboxyl functionality in a protected, esterified form. The molecule contains a stereogenic center at the α-position consistent with L-lysine configuration, while the hydrochloride salt form increases handling stability and supports controlled downstream transformations of the basic amino group. The Bz group on the α-amino nitrogen and the methyl ester at the carboxylate establish a clear protecting-group logic for peptide coupling chemistry and selective deprotection sequences. The ε-amino side chain remains available for orthogonal protection, nucleophilic derivatization, or orthogonally protected amino acid incorporation, making the compound a practical chiral intermediate for amino acid modification and peptidic scaffold construction.

1. Protected Amino Acid Synthesis

Bz-L-Lys-OMe*HCl supports protected amino acid synthesis workflows in fine chemical and research-grade intermediate preparation by combining an N-protecting Bz group with a methyl ester that can be carried through coupling steps. The α-amide-forming nitrogen is protected as the benzylcarbonyl derivative, while the esterified carboxyl group can be converted to activated carboxyl equivalents for peptide coupling or further functional group interconversions. The L stereochemistry is preserved through standard derivatization logic, enabling reproducible chiral building block use for downstream protected amino acid chemistry. The hydrochloride salt form can facilitate consistent handling of the basic lysine functionality during manufacturing-scale intermediate processing and analytical verification.

2. Peptide Synthesis

Bz-L-Lys-OMe*HCl is suitable for peptide building block preparation where lysine side-chain chemistry must be introduced with controlled protection and predictable coupling behavior. The Bz-protected α-amino group aligns with common peptide coupling strategies by preventing undesired branching reactions at the α-nitrogen, while the methyl ester provides a defined carboxyl handle for conversion to peptide-ready forms. The ε-amino side chain can be selectively protected after ester handling to enable orthogonal deprotection during peptide assembly, supporting lysine-containing peptide synthesis and segment coupling. The resulting lysine-containing intermediates can be used for constructing peptide sequences that require controlled side-chain reactivity, including peptide analogs used in biochemical research and process chemistry for peptide-grade materials.

3. Side-Chain Functionalization

Bz-L-Lys-OMe*HCl enables side-chain functionalization programs targeting the ε-amino group of lysine for generating conjugation-ready or recognition-tuned derivatives. The presence of a protected α-amino nitrogen and an esterified carboxyl group reduces competing reactivity, allowing derivatization of the free ε-amino functionality through acylation, alkylation, or orthogonal protection strategies compatible with later peptide or conjugation steps. The chiral lysine backbone supports stereochemically defined products that can be carried into peptidomimetic construction or chemical biology probes. The hydrochloride salt can improve reproducibility in base/acid handling during intermediate derivatization, supporting consistent downstream formation of functionalized amino acid derivatives used in synthetic organic chemistry and applied research.

4. Bioconjugation Chemistry

Bz-L-Lys-OMe*HCl can be employed in bioconjugation chemistry workflows where lysine-derived amine reactivity is leveraged to attach linkers, tags, or reactive handles to biomolecule scaffolds. The compound's protected α-amino group and esterified carboxyl group help localize reactivity to the ε-amino side chain for controlled introduction of conjugation motifs while maintaining a defined stereochemical framework. Orthogonal protection of the ε-amino group after salt handling can enable stepwise synthesis of conjugates that require selective deprotection timing or staged coupling to biomolecules. The lysine-based intermediate can serve as a precursor for generating labeled peptides, linker-bearing amino acid derivatives, and conjugation reagents used in biochemical research and specialty chemical production.

5. Pharmaceutical Manufacturing Intermediates

Bz-L-Lys-OMe*HCl is applicable to pharmaceutical manufacturing intermediate preparation where lysine-containing chiral building blocks are required for peptide-like active ingredients or process intermediates. The Bz-protected α-amino functionality and methyl ester provide a manufacturable protection pattern that can be converted into peptide coupling-ready carboxyl derivatives and later deprotected under controlled conditions to yield the corresponding free amino acid or activated peptide fragment. The L configuration supports stereochemical fidelity across multistep syntheses, which is relevant for consistent quality of downstream intermediates and final product precursors. The hydrochloride salt form supports handling stability for basic intermediates, aligning with industrial process chemistry needs for reliable feedstock behavior, in-process control, and downstream analytical traceability.

1. Extended exenatide administration enhances lipid metabolism and exacerbates pancreatic injury in mice on a high fat, high carbohydrate diet

2. Olfactory receptor based piezoelectric biosensors for detection of alcohols related to food safety applications

3. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy

4. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review

5. Immune responses to peptides containing homocitrulline or citrulline in the DR4-transgenic mouse model of rheumatoid arthritis